3-[1-(cyclopropylmethyl)-4-methylbenzotriazol-5-yl]-2,2-dimethyl-3-[5-methyl-6-[[7-(2-morpholin-4-ylethoxy)-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl]methyl]-2-pyridinyl]propanoic acid

C40H51N7O8S — CID 146372421

IUPAC3-[1-(cyclopropylmethyl)-4-methylbenzotriazol-5-yl]-2,2-dimethyl-3-[5-methyl-6-[[7-(2-morpholin-4-ylethoxy)-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl]methyl]-2-pyridinyl]propanoic acid
SMILESCc1ccc(C(c2ccc3c(nnn3CC3CC3)c2C)C(C)(C)C(=O)O)nc1CN1CC2(CCOCC2)Oc2nc(OCCN3CCOCC3)ccc2S1(=O)=O
InChIInChI=1S/C40H51N7O8S/c1-26-5-9-30(35(39(3,4)38(48)49)29-8-10-32-36(27(29)2)43-44-47(32)23-28-6-7-28)41-31(26)24-46-25-40(13-18-52-19-14-40)55-37-33(56(46,50)51)11-12-34(42-37)54-22-17-45-15-20-53-21-16-45/h5,8-12,28,35H,6-7,13-25H2,1-4H3,(H,48,49)
InChIKeyRQIPWZHHOWQZJE-UHFFFAOYSA-N
MW789.96 g/mol
LogP4.33
Rot. Bonds12

About 3-[1-(cyclopropylmethyl)-4-methylbenzotriazol-5-yl]-2,2-dimethyl-3-[5-methyl-6-[[7-(2-morpholin-4-ylethoxy)-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl]methyl]-2-pyridinyl]propanoic acid

3-[1-(cyclopropylmethyl)-4-methylbenzotriazol-5-yl]-2,2-dimethyl-3-[5-methyl-6-[[7-(2-morpholin-4-ylethoxy)-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl]methyl]-2-pyridinyl]propanoic acid (PubChem CID 146372421) has the molecular formula C40H51N7O8S and a molecular weight of 789.96 g/mol. Its IUPAC name is 3-[1-(cyclopropylmethyl)-4-methylbenzotriazol-5-yl]-2,2-dimethyl-3-[5-methyl-6-[[7-(2-morpholin-4-ylethoxy)-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl]methyl]-2-pyridinyl]propanoic acid.

Molecular Properties

Compound Name3-[1-(cyclopropylmethyl)-4-methylbenzotriazol-5-yl]-2,2-dimethyl-3-[5-methyl-6-[[7-(2-morpholin-4-ylethoxy)-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl]methyl]-2-pyridinyl]propanoic acid
PubChem CID146372421
Molecular FormulaC40H51N7O8S
Molecular Weight789.96 g/mol
Exact Mass789.35
IUPAC Name3-[1-(cyclopropylmethyl)-4-methylbenzotriazol-5-yl]-2,2-dimethyl-3-[5-methyl-6-[[7-(2-morpholin-4-ylethoxy)-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl]methyl]-2-pyridinyl]propanoic acid
SMILESCc1ccc(C(c2ccc3c(nnn3CC3CC3)c2C)C(C)(C)C(=O)O)nc1CN1CC2(CCOCC2)Oc2nc(OCCN3CCOCC3)ccc2S1(=O)=O
InChIInChI=1S/C40H51N7O8S/c1-26-5-9-30(35(39(3,4)38(48)49)29-8-10-32-36(27(29)2)43-44-47(32)23-28-6-7-28)41-31(26)24-46-25-40(13-18-52-19-14-40)55-37-33(56(46,50)51)11-12-34(42-37)54-22-17-45-15-20-53-21-16-45/h5,8-12,28,35H,6-7,13-25H2,1-4H3,(H,48,49)
InChIKeyRQIPWZHHOWQZJE-UHFFFAOYSA-N
XLogP4.33
TPSA171.33 Ų
H-Bond Donors1
H-Bond Acceptors13
Rotatable Bonds12
Heavy Atoms56
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500789.96
LogP ≤ 54.33
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1013

Analyze 3-[1-(cyclopropylmethyl)-4-methylbenzotriazol-5-yl]-2,2-dimethyl-3-[5-methyl-6-[[7-(2-morpholin-4-ylethoxy)-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl]methyl]-2-pyridinyl]propanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[1-(cyclopropylmethyl)-4-methylbenzotriazol-5-yl]-2,2-dimethyl-3-[5-methyl-6-[[7-(2-morpholin-4-ylethoxy)-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl]methyl]-2-pyridinyl]propanoic acid?
The IUPAC name of 3-[1-(cyclopropylmethyl)-4-methylbenzotriazol-5-yl]-2,2-dimethyl-3-[5-methyl-6-[[7-(2-morpholin-4-ylethoxy)-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl]methyl]-2-pyridinyl]propanoic acid (CID 146372421) is 3-[1-(cyclopropylmethyl)-4-methylbenzotriazol-5-yl]-2,2-dimethyl-3-[5-methyl-6-[[7-(2-morpholin-4-ylethoxy)-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl]methyl]-2-pyridinyl]propanoic acid.
What is the SMILES notation for 3-[1-(cyclopropylmethyl)-4-methylbenzotriazol-5-yl]-2,2-dimethyl-3-[5-methyl-6-[[7-(2-morpholin-4-ylethoxy)-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl]methyl]-2-pyridinyl]propanoic acid?
The canonical SMILES for 3-[1-(cyclopropylmethyl)-4-methylbenzotriazol-5-yl]-2,2-dimethyl-3-[5-methyl-6-[[7-(2-morpholin-4-ylethoxy)-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl]methyl]-2-pyridinyl]propanoic acid is Cc1ccc(C(c2ccc3c(nnn3CC3CC3)c2C)C(C)(C)C(=O)O)nc1CN1CC2(CCOCC2)Oc2nc(OCCN3CCOCC3)ccc2S1(=O)=O.
What is the InChIKey of 3-[1-(cyclopropylmethyl)-4-methylbenzotriazol-5-yl]-2,2-dimethyl-3-[5-methyl-6-[[7-(2-morpholin-4-ylethoxy)-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl]methyl]-2-pyridinyl]propanoic acid?
The InChIKey is RQIPWZHHOWQZJE-UHFFFAOYSA-N. The full InChI is InChI=1S/C40H51N7O8S/c1-26-5-9-30(35(39(3,4)38(48)49)29-8-10-32-36(27(29)2)43-44-47(32)23-28-6-7-28)41-31(26)24-46-25-40(13-18-52-19-14-40)55-37-33(56(46,50)51)11-12-34(42-37)54-22-17-45-15-20-53-21-16-45/h5,8-12,28,35H,6-7,13-25H2,1-4H3,(H,48,49).
What are the key properties of 3-[1-(cyclopropylmethyl)-4-methylbenzotriazol-5-yl]-2,2-dimethyl-3-[5-methyl-6-[[7-(2-morpholin-4-ylethoxy)-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl]methyl]-2-pyridinyl]propanoic acid?
3-[1-(cyclopropylmethyl)-4-methylbenzotriazol-5-yl]-2,2-dimethyl-3-[5-methyl-6-[[7-(2-morpholin-4-ylethoxy)-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl]methyl]-2-pyridinyl]propanoic acid has a molecular weight of 789.96 g/mol, XLogP of 4.33, 12 rotatable bonds, 1 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[1-(cyclopropylmethyl)-4-methylbenzotriazol-5-yl]-2,2-dimethyl-3-[5-methyl-6-[[7-(2-morpholin-4-ylethoxy)-1,1-dioxospiro[3H-pyrido[2,3-b][1,4,5]oxathiazepine-4,4'-oxane]-2-yl]methyl]-2-pyridinyl]propanoic acid is sourced from PubChem (CID 146372421), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).